[Skip to Content]

SSR Contraceptive Symposium Call for Abstracts

The Contraceptive Symposium Organizing Committee welcomes abstracts reporting new basic, clinical, and/or translational research in any field of reproduction that may have relevance to contraceptive innovation or discovery. You do not need to be a Member of SSR to submit an abstract. There are no restrictions on species investigated. Please adhere to all rules for the submission and format of abstracts.

Failure to comply may be cause for rejection.

Confirmation of Submission

All authors of each abstract will receive an automated e-mail confirmation containing a submission ID number.

Program Assignments

The Contraceptive Symposium Organizing Committee will review each abstract for scientific merit and content. Each abstract will be assigned to either an oral presentation or e-Poster presentation session.

Each of the three Symposium sessions will include one keynote presentation, 3 invited talks of 15 minutes each, and 2-3 short oral presentations (10 minutes each) selected from the submitted abstracts. Invited speakers will have a separate abstract submission process and will receive notification at the time the site is open to upload invited abstracts.

At submission, you must choose at least one most appropriate category for your presentation from the following list:

  • Hypothalamus/Pituitary
  • Female Tract
  • Ovary / Ovarian Follicle / Ovulation
  • Oocytes
  • Male Tract / Accessory Glands
  • Spermatogenesis / Blood-testis Barrier
  • Sperm
  • Fertilization / Embryo
  • Implantation
  • Contraceptive Drugs and Devices
  • Contraceptive Discovery / Testing Platforms
  • Contraceptive Use / Behavior / Side Effects

You must indicate whether or not you would be willing, if selected, to give an Oral Presentation. Choosing an oral presentation does NOT ensure you will be selected for an oral presentation. Members of the Contraceptive Symposium Organizing Committee as invited reviewers will review all submitted abstracts. Outstanding abstracts that fit the topic of each specific Symposia will be selected by the Contraceptive symposium organizing committee for oral presentation.

Posters: All posters will be presented as recorded e-Poster presentations of ~ 5 minutes length and presented online through the conference website to be viewed only by registered conference. Poster presenters are encouraged to provide an audio description of their posters that attendees can access while viewing the e-Poster online.


 

All Abstracts Must Be Submitted Online

The submission deadline is 11:59 PM (EST) on Friday, July 2nd, 2021. Please see the Submission Procedures below for specific instructions. You will be able to save your submission-in-progress in the system; however, the submission must be completed and uploaded by the submission deadline.

Notification of Acceptance

All authors will be notified by e-mail of the Contraceptive Symposium Organizing Committee’s decision regarding acceptance of the abstract for either poster or oral presentation.

Rules Governing Submission of Abstracts

  1. General Requirements: Data and conclusions presented at the meeting must be based on the same research described in the submitted abstract. It is expected that the abstract and presentation will contain new and unpublished information.
     
  2. SSR Membership: Membership in SSR is not a prerequisite for submission of an abstract.
     
  3. Authorship: An individual may be selected to present only one abstract as an oral talk at the meeting and abstracts not selected for oral presentation will be expected to be presented by the first author as a poster. However, an author's name may appear on multiple abstracts as a co-author. Every author must have a unique e-mail address at which they may be contacted. All authors will be notified when the abstract is submitted, as well as of the committee’s decision of acceptance/rejection, and mode of presentation (oral/poster). Please contact co-authors prior to submission.
     
  4. Presentation: The first author must present the abstract. Any exception must be approved by the Contraceptive Symposium Organizing Committee more than one week prior to the start of the meeting. Only an existing co-author of the abstract will be considered an acceptable replacement, and that co-author cannot be presenting another oral presentation at this meeting. Each co-author must agree in principle with the information and conclusions contained within the abstract.
     
  5. Meeting Attendance: Submission of an abstract constitutes an agreement that the presenting author will attend the virtual meeting to present the abstract if the abstract is accepted. The presenting author must register for the Symposia before the registration deadline. If the presenting author has not registered by this deadline and is chosen for an Oral Talk, the meeting staff will attempt to contact the author. If the presenting author does not respond in a timely manner, another abstract will be chosen for oral presentation.
     
  6. Certification: The presenting author must certify that the conditions for submission have been satisfied and that all animal and human welfare and ethical considerations have been met. Abstracts that violate these ethics will be rejected.
     
  7. Content: Abstracts must be written in clear, concise, and grammatically correct English. The body of the abstract must contain the following:

    1. statement of specific objectives or hypotheses

    2. brief statement of methods, if pertinent

    3. summary of results (including number of subjects per group or number of replicates per treatment), pertinent data, and statistical analyses

    4. statement of conclusions

    Please view the sample abstracts document for layout and formatting examples. Financial support may be listed at the end of the abstract but is not required. Do not use headers (e.g., objectives, methods) in your abstract. Do not put in any paragraph breaks. Do not use phrases such as "will be discussed" or "will be presented." Avoid abbreviations and acronyms, and do not cite references. Do not include tables or figures. Abstracts may not contain any type of advertising or logo, including trademark and copyright symbols.

    Nomenclature: The SSR requires use of approved gene and protein nomenclature. Please refer to the Nomenclature Guidelines and Requirements for the Society's journal, Biology of Reproduction, for specific instructions for gene/protein names/symbols and correct formatting.

  8. Format: Presentation Title: The title cannot exceed 150 characters. Type the title in lower case with initial letters capitalized (title case). Please use appropriate ending punctuation (period/full stop or question mark). Special characters (e.g., Greek characters) will be retained in the title. Do not use any formatting for genetic or scientific nomenclature such as superscripts, subscripts, bold and italics, they will not be retained.
     
  9. The Abstract: Excluding title, authors, and affiliations—may not exceed 500 words. It is recommended that abstracts be created in a word processing program, then cut and pasted into the display box provided on the abstract site.
     
  10. Competitions: One presenter whose abstract was selected for an oral talk will be selected from each symposium session for best abstract/ presentation. The Contraceptive Symposium Organizing Committee will select finalists on the basis of an evaluation of the abstracts submitted for competition. Awards will be announced at the end of each final symposium on Thursday August 5th at the SSR Business Meeting.
     
  11. Withdrawal: If an abstract must be withdrawn, written notice of withdrawal—signed by the presenting author—must be submitted (by fax, e-mail, or regular mail) to the SSR Business Office. This notice must state the reason(s) for withdrawal of the abstract and attest that all authors agree that the abstract must be withdrawn. All authors will receive a written confirmation of the withdrawal by e-mail. Notification of withdrawal of an abstract must be received not later than 1 week prior to the presentation.
  12. Disclosure of Affiliations and Conflicts of Interest: Each author must disclose any financial, personal, or professional relationships with other people or organizations that could reasonably be perceived as conflicts of interest or as potentially influencing or biasing their work. Author(s) disclosure(s) must appear on the oral abstract presentation slides or poster presentation board.